NCT00656539

Safety and Efficacy Pilot Study of AzaSite® for Four Weeks in Subjects With Blepharitis

A Single-Center, Open-Label, Randomized Pilot Study of the Safety and Efficacy of AzaSite® Ophthalmic Solution, 1% in Combination With Mechanical Therapy Versus Mechanical Therapy Alone for Four Weeks in Subjects With Posterior Blepharitis

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 20 (estimated)
• Sponsor: Merck Sharp & Dohme LLC · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate the safety and efficacy of AzaSite® ophthalmic solution, 1% on signs and symptoms of blepharitis.

Conditions

• Blepharitis

Interventions

Type	Name	Description
DRUG	AzaSite®	Ophthalmic solution; 1 drop in each eye BID for two days, then 1 drop in each eye QD for \~26 days

Timeline

• Start date: 2008-04-01
• Primary completion: 2008-11-01
• First posted: 2008-04-11
• Last updated: 2011-09-26

Locations

1 site across 1 country: United States